-
1
-
-
14944375587
-
Immunology of hepatitis B virus and hepatitis C virus infection
-
Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5: 215-229.
-
(2005)
Nat. Rev. Immunol.
, vol.5
, pp. 215-229
-
-
Rehermann, B.1
Nascimbeni, M.2
-
2
-
-
70449724811
-
Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus
-
Wang, F. S., and Z. Zhang. 2009. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev. Gastroenterol. Hepatol. 3: 499-512.
-
(2009)
Expert Rev. Gastroenterol. Hepatol.
, vol.3
, pp. 499-512
-
-
Wang, F.S.1
Zhang, Z.2
-
3
-
-
84868702241
-
Innate and adaptive immune responses in chronic hepatitis B virus infections: Towards restoration of immune control of viral infection
-
Bertoletti, A., and C. Ferrari. 2012. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61: 1754-1764.
-
(2012)
Gut
, vol.61
, pp. 1754-1764
-
-
Bertoletti, A.1
Ferrari, C.2
-
4
-
-
79955112364
-
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
-
Schurich, A., P. Khanna, A. R. Lopes, K. J. Han, D. Peppa, L. Micco, G. Nebbia, P. T. Kennedy, A. M. Geretti, G. Dusheiko, and M. K. Maini. 2011. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 53: 1494-1503.
-
(2011)
Hepatology
, vol.53
, pp. 1494-1503
-
-
Schurich, A.1
Khanna, P.2
Lopes, A.R.3
Han, K.J.4
Peppa, D.5
Micco, L.6
Nebbia, G.7
Kennedy, P.T.8
Geretti, A.M.9
Dusheiko, G.10
Maini, M.K.11
-
5
-
-
54049134747
-
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
-
Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
-
(2008)
J. Immunol.
, vol.181
, pp. 5791-5802
-
-
Youn, J.I.1
Nagaraj, S.2
Collazo, M.3
Gabrilovich, D.I.4
-
7
-
-
84883447186
-
low/- myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
-
low/- myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunol. Immunother. 62: 1439-1451.
-
(2013)
Cancer Immunol. Immunother.
, vol.62
, pp. 1439-1451
-
-
Huang, A.1
Zhang, B.2
Wang, B.3
Zhang, F.4
Fan, K.X.5
Guo, Y.J.6
-
9
-
-
46049098560
-
+ T cells
-
+ T cells. Gastroenterology 135: 234-243.
-
(2008)
Gastroenterology
, vol.135
, pp. 234-243
-
-
Hoechst, B.1
Ormandy, L.A.2
Ballmaier, M.3
Lehner, F.4
Krüuger, C.5
Manns, M.P.6
Greten, T.F.7
Korangy, F.8
-
10
-
-
34447258415
-
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine
-
Filipazzi, P., R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, and L. Rivoltini. 2007. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25: 2546-2553.
-
(2007)
J. Clin. Oncol.
, vol.25
, pp. 2546-2553
-
-
Filipazzi, P.1
Valenti, R.2
Huber, V.3
Pilla, L.4
Canese, P.5
Iero, M.6
Castelli, C.7
Mariani, L.8
Parmiani, G.9
Rivoltini, L.10
-
11
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
-
(2009)
Nat. Rev. Immunol.
, vol.9
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
12
-
-
33749461167
-
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
-
Mirza, N., M. Fishman, I. Fricke, M. Dunn, A. M. Neuger, T. J. Frost, R. M. Lush, S. Antonia, and D. I. Gabrilovich. 2006. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 66: 9299-9307.
-
(2006)
Cancer Res.
, vol.66
, pp. 9299-9307
-
-
Mirza, N.1
Fishman, M.2
Fricke, I.3
Dunn, M.4
Neuger, A.M.5
Frost, T.J.6
Lush, R.M.7
Antonia, S.8
Gabrilovich, D.I.9
-
13
-
-
84864662070
-
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
-
Walter, S., T. Weinschenk, A. Stenzl, R. Zdrojowy, A. Pluzanska, C. Szczylik, M. Staehler, W. Brugger, P. Y. Dietrich, R. Mendrzyk, et al. 2012. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med. 18: 1254-1261.
-
(2012)
Nat. Med.
, vol.18
, pp. 1254-1261
-
-
Walter, S.1
Weinschenk, T.2
Stenzl, A.3
Zdrojowy, R.4
Pluzanska, A.5
Szczylik, C.6
Staehler, M.7
Brugger, W.8
Dietrich, P.Y.9
Mendrzyk, R.10
-
14
-
-
84875866083
-
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
-
Vasquez-Dunddel, D., F. Pan, Q. Zeng, M. Gorbounov, E. Albesiano, J. Fu, R. L. Blosser, A. J. Tam, T. Bruno, H. Zhang, et al. 2013. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J. Clin. Invest. 123: 1580-1589.
-
(2013)
J. Clin. Invest.
, vol.123
, pp. 1580-1589
-
-
Vasquez-Dunddel, D.1
Pan, F.2
Zeng, Q.3
Gorbounov, M.4
Albesiano, E.5
Fu, J.6
Blosser, R.L.7
Tam, A.J.8
Bruno, T.9
Zhang, H.10
-
15
-
-
84905112825
-
lo myeloid-derived suppressor cells that inhibit Tcell responses and promote TRegs
-
lo myeloid-derived suppressor cells that inhibit Tcell responses and promote TRegs. Blood 124: 750-760.
-
(2014)
Blood
, vol.124
, pp. 750-760
-
-
Jitschin, R.1
Braun, M.2
Büuttner, M.3
Dettmer-Wilde, K.4
Bricks, J.5
Berger, J.6
Eckart, M.J.7
Krause, S.W.8
Oefner, P.J.9
Le Blanc, K.10
-
16
-
-
51249105349
-
Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway
-
e5
-
Haile, L. A., R. von Wasielewski, J. Gamrekelashvili, C. Kruger, O. Bachmann, A. M. Westendorf, J. Buer, R. Liblau, M. P. Manns, F. Korangy, and T. F. Greten. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881.e5.
-
(2008)
Gastroenterology
, vol.135
, pp. 871-881
-
-
Haile, L.A.1
Von Wasielewski, R.2
Gamrekelashvili, J.3
Kruger, C.4
Bachmann, O.5
Westendorf, A.M.6
Buer, J.7
Liblau, R.8
Manns, M.P.9
Korangy, F.10
Greten, T.F.11
-
17
-
-
84864289043
-
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
-
Vollbrecht, T., R. Stirner, A. Tufman, J. Roider, R. M. Huber, J. R. Bogner, A. Lechner, C. Bourquin, and R. Draenert. 2012. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26: F31-F37.
-
(2012)
Aids
, vol.26
, pp. F31-F37
-
-
Vollbrecht, T.1
Stirner, R.2
Tufman, A.3
Roider, J.4
Huber, R.M.5
Bogner, J.R.6
Lechner, A.7
Bourquin, C.8
Draenert, R.9
-
18
-
-
84901409117
-
+ T cells in chronic hepatitis C patients
-
+ T cells in chronic hepatitis C patients. Mol. Cells 37: 66-73.
-
(2014)
Mol. Cells
, vol.37
, pp. 66-73
-
-
Zeng, Q.L.1
Yang, B.2
Sun, H.Q.3
Feng, G.H.4
Jin, L.5
Zou, Z.S.6
Zhang, Z.7
Zhang, J.Y.8
Wang, F.S.9
-
19
-
-
84878017037
-
Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients
-
Cai, W., A. Qin, P. Guo, D. Yan, F. Hu, Q. Yang, M. Xu, Y. Fu, J. Zhou, and X. Tang. 2013. Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J. Clin. Immunol. 33: 798-808.
-
(2013)
J. Clin. Immunol.
, vol.33
, pp. 798-808
-
-
Cai, W.1
Qin, A.2
Guo, P.3
Yan, D.4
Hu, F.5
Yang, Q.6
Xu, M.7
Fu, Y.8
Zhou, J.9
Tang, X.10
-
20
-
-
84863012062
-
Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species
-
Tacke, R. S., H. C. Lee, C. Goh, J. Courtney, S. J. Polyak, H. R. Rosen, and Y. S. Hahn. 2012. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55: 343-353.
-
(2012)
Hepatology
, vol.55
, pp. 343-353
-
-
Tacke, R.S.1
Lee, H.C.2
Goh, C.3
Courtney, J.4
Polyak, S.J.5
Rosen, H.R.6
Hahn, Y.S.7
-
21
-
-
84873049826
-
Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals
-
Qin, A., W. Cai, T. Pan, K. Wu, Q. Yang, N. Wang, Y. Liu, D. Yan, F. Hu, P. Guo, et al. 2013. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87: 1477-1490.
-
(2013)
J. Virol.
, vol.87
, pp. 1477-1490
-
-
Qin, A.1
Cai, W.2
Pan, T.3
Wu, K.4
Yang, Q.5
Wang, N.6
Liu, Y.7
Yan, D.8
Hu, F.9
Guo, P.10
-
22
-
-
84892646386
-
HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity
-
Garg, A., and S. A. Spector. 2014. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J. Infect. Dis. 209: 441-451.
-
(2014)
J. Infect. Dis.
, vol.209
, pp. 441-451
-
-
Garg, A.1
Spector, S.A.2
-
23
-
-
84862664371
-
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
-
European Association for the Study of the Liver. 2012. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J. Hepatol. 57: 167-185.
-
(2012)
J. Hepatol.
, vol.57
, pp. 167-185
-
-
European Association for the Study of the Liver1
-
24
-
-
0026072529
-
Classification of chronic viral hepatitis: A need for reassessment
-
Scheuer, P. J. 1991. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13: 372-374.
-
(1991)
J. Hepatol.
, vol.13
, pp. 372-374
-
-
Scheuer, P.J.1
-
25
-
-
76249097154
-
Immune effectors required for hepatitis B virus clearance
-
Yang, P. L., A. Althage, J. Chung, H. Maier, S. Wieland, M. Isogawa, and F. V. Chisari. 2010. Immune effectors required for hepatitis B virus clearance. Proc. Natl. Acad. Sci. USA 107: 798-802.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 798-802
-
-
Yang, P.L.1
Althage, A.2
Chung, J.3
Maier, H.4
Wieland, S.5
Isogawa, M.6
Chisari, F.V.7
-
26
-
-
79952305123
-
Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B
-
Zhang, J. Y., Z. S. Zou, A. Huang, Z. Zhang, J. L. Fu, X. S. Xu, L. M. Chen, B. S. Li, and F. S. Wang. 2011. Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS ONE 6: e17484.
-
(2011)
Plos One
, vol.6
-
-
Zhang, J.Y.1
Zou, Z.S.2
Huang, A.3
Zhang, Z.4
Fu, J.L.5
Xu, X.S.6
Chen, L.M.7
Li, B.S.8
Wang, F.S.9
-
27
-
-
76149145359
-
low/- monocytes in prostate cancer
-
Vuk-Pavlović, S., P. A. Bulur, Y. Lin, R. Qin, C. L. Szumlanski, X. Zhao, and A. B. Dietz. 2010. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. Prostate 70: 443-455.
-
(2010)
Prostate
, vol.70
, pp. 443-455
-
-
Vuk-Pavlović, S.1
Bulur, P.A.2
Lin, Y.3
Qin, R.4
Szumlanski, C.L.5
Zhao, X.6
Dietz, A.B.7
-
28
-
-
34250005419
-
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
-
Fu, J., D. Xu, Z. Liu, M. Shi, P. Zhao, B. Fu, Z. Zhang, H. Yang, H. Zhang, C. Zhou, et al. 2007. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132: 2328-2339.
-
(2007)
Gastroenterology
, vol.132
, pp. 2328-2339
-
-
Fu, J.1
Xu, D.2
Liu, Z.3
Shi, M.4
Zhao, P.5
Fu, B.6
Zhang, Z.7
Yang, H.8
Zhang, H.9
Zhou, C.10
-
29
-
-
77953141534
-
hi and overexpress CD80, CD83, and DC-sign
-
Poschke, I., D. Mougiakakos, J. Hansson, G. V. Masucci, and R. Kiessling. 2010. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 70: 4335-4345.
-
(2010)
Cancer Res.
, vol.70
, pp. 4335-4345
-
-
Poschke, I.1
Mougiakakos, D.2
Hansson, J.3
Masucci, G.V.4
Kiessling, R.5
-
30
-
-
64749115624
-
Imbalanced intrahepatic cytokine expression of interferongamma, tumor necrosis factor-α, and interleukin-10 in patients with acute-onchronic liver failure associated with hepatitis B virus infection
-
Zou, Z., B. Li, D. Xu, Z. Zhang, J. M. Zhao, G. Zhou, Y. Sun, L. Huang, J. Fu, Y. Yang, et al. 2009. Imbalanced intrahepatic cytokine expression of interferongamma, tumor necrosis factor-α, and interleukin-10 in patients with acute-onchronic liver failure associated with hepatitis B virus infection. J. Clin. Gastroenterol. 43: 182-190.
-
(2009)
J. Clin. Gastroenterol.
, vol.43
, pp. 182-190
-
-
Zou, Z.1
Li, B.2
Xu, D.3
Zhang, Z.4
Zhao, J.M.5
Zhou, G.6
Sun, Y.7
Huang, L.8
Fu, J.9
Yang, Y.10
-
31
-
-
65449117946
-
Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
-
Brunetto, M. R., F. Moriconi, F. Bonino, G. K. Lau, P. Farci, C. Yurdaydin, T. Piratvisuth, K. Luo, Y. Wang, S. Hadziyannis, et al. 2009. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 49: 1141-1150.
-
(2009)
Hepatology
, vol.49
, pp. 1141-1150
-
-
Brunetto, M.R.1
Moriconi, F.2
Bonino, F.3
Lau, G.K.4
Farci, P.5
Yurdaydin, C.6
Piratvisuth, T.7
Luo, K.8
Wang, Y.9
Hadziyannis, S.10
-
32
-
-
77957991455
-
Myeloid-derived suppressor cells in human cancer
-
Nagaraj, S., and D. I. Gabrilovich. 2010. Myeloid-derived suppressor cells in human cancer. Cancer J. 16: 348-353.
-
(2010)
Cancer J.
, vol.16
, pp. 348-353
-
-
Nagaraj, S.1
Gabrilovich, D.I.2
-
33
-
-
84901992636
-
Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals
-
Nonnenmann, J., R. Stirner, J. Roider, M. C. Jung, K. Schrödl, J. R. Bogner, and R. Draenert. 2014. Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals. J. Virol. 88: 7678-7682.
-
(2014)
J. Virol.
, vol.88
, pp. 7678-7682
-
-
Nonnenmann, J.1
Stirner, R.2
Roider, J.3
Jung, M.C.4
Schrödl, K.5
Bogner, J.R.6
Draenert, R.7
-
34
-
-
80052646150
-
Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus
-
Chen, S., S. M. Akbar, M. Abe, Y. Hiasa, and M. Onji. 2011. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin. Exp. Immunol. 166: 134-142.
-
(2011)
Clin. Exp. Immunol.
, vol.166
, pp. 134-142
-
-
Chen, S.1
Akbar, S.M.2
Abe, M.3
Hiasa, Y.4
Onji, M.5
-
35
-
-
24944509220
-
T cells and viral persistence: Lessons from diverse infections
-
Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6: 873-879.
-
(2005)
Nat. Immunol.
, vol.6
, pp. 873-879
-
-
Klenerman, P.1
Hill, A.2
-
36
-
-
0035871869
-
Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B
-
Buti, M., F. Sánchez, M. Cotrina, R. Jardi, F. Rodríguez, R. Esteban, and J. Guardia. 2001. Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B. J. Infect. Dis. 183: 1277-1280.
-
(2001)
J. Infect. Dis.
, vol.183
, pp. 1277-1280
-
-
Buti, M.1
Sánchez, F.2
Cotrina, M.3
Jardi, R.4
Rodríguez, F.5
Esteban, R.6
Guardia, J.7
-
37
-
-
0036793250
-
Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation
-
Castells, L., V. Vargas, F. Rodríguez, H. Allende, M. Buti, J. F. Sánchez-Avila, R. Jardí, C. Margarit, T. Pumarola, R. Esteban, and J. Guardia. 2002. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transpl. 8: 892-900.
-
(2002)
Liver Transpl.
, vol.8
, pp. 892-900
-
-
Castells, L.1
Vargas, V.2
Rodríguez, F.3
Allende, H.4
Buti, M.5
Sánchez-Avila, J.F.6
Jardí, R.7
Margarit, C.8
Pumarola, T.9
Esteban, R.10
Guardia, J.11
-
38
-
-
84869223841
-
+ monocytic myeloid-derived suppressor cells and their clinical relevance in nonsmall cell lung cancer
-
+ monocytic myeloid-derived suppressor cells and their clinical relevance in nonsmall cell lung cancer. Am. J. Respir. Crit. Care Med. 186: 1025-1036.
-
(2012)
Am. J. Respir. Crit. Care Med.
, vol.186
, pp. 1025-1036
-
-
Feng, P.H.1
Lee, K.Y.2
Chang, Y.L.3
Chan, Y.F.4
Kuo, L.W.5
Lin, T.Y.6
Chung, F.T.7
Kuo, C.S.8
Yu, C.T.9
Lin, S.M.10
-
39
-
-
41149145956
-
Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production
-
Saito, K., M. Ait-Goughoulte, S. M. Truscott, K. Meyer, A. Blazevic, G. Abate, R. B. Ray, D. F. Hoft, and R. Ray. 2008. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J. Virol. 82: 3320-3328.
-
(2008)
J. Virol.
, vol.82
, pp. 3320-3328
-
-
Saito, K.1
Ait-Goughoulte, M.2
Truscott, S.M.3
Meyer, K.4
Blazevic, A.5
Abate, G.6
Ray, R.B.7
Hoft, D.F.8
Ray, R.9
-
40
-
-
84869221347
-
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer
-
Hart, K. M., K. T. Byrne, M. J. Molloy, E. M. Usherwood, and B. Berwin. 2011. IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer. Front. Immunol. 2: 29.
-
(2011)
Front. Immunol.
, vol.2
, pp. 29
-
-
Hart, K.M.1
Byrne, K.T.2
Molloy, M.J.3
Usherwood, E.M.4
Berwin, B.5
-
41
-
-
77956920766
-
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells
-
Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
-
(2010)
J. Immunol.
, vol.185
, pp. 2273-2284
-
-
Lechner, M.G.1
Liebertz, D.J.2
Epstein, A.L.3
-
42
-
-
77950525439
-
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4 + T cell activation during HIV infection
-
Said, E. A., F. P. Dupuy, L. Trautmann, Y. Zhang, Y. Shi, M. El-Far, B. J. Hill, A. Noto, P. Ancuta, Y. Peretz, et al. 2010. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4 + T cell activation during HIV infection. Nat. Med. 16: 452-459.
-
(2010)
Nat. Med.
, vol.16
, pp. 452-459
-
-
Said, E.A.1
Dupuy, F.P.2
Trautmann, L.3
Zhang, Y.4
Shi, Y.5
El-Far, M.6
Hill, B.J.7
Noto, A.8
Ancuta, P.9
Peretz, Y.10
-
43
-
-
65249138393
-
Myeloid-derived suppressor cells: Linking inflammation and cancer
-
Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
-
(2009)
J. Immunol.
, vol.182
, pp. 4499-4506
-
-
Ostrand-Rosenberg, S.1
Sinha, P.2
-
44
-
-
29644442445
-
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression
-
Bunt, S. K., P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg. 2006. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176: 284-290.
-
(2006)
J. Immunol.
, vol.176
, pp. 284-290
-
-
Bunt, S.K.1
Sinha, P.2
Clements, V.K.3
Leips, J.4
Ostrand-Rosenberg, S.5
-
45
-
-
84874260474
-
Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity
-
Norris, B. A., L. S. Uebelhoer, H. I. Nakaya, A. A. Price, A. Grakoui, and B. Pulendran. 2013. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38: 309-321.
-
(2013)
Immunity
, vol.38
, pp. 309-321
-
-
Norris, B.A.1
Uebelhoer, L.S.2
Nakaya, H.I.3
Price, A.A.4
Grakoui, A.5
Pulendran, B.6
|